Biomerica, Inc. (BMRA)
USD 0.54
(-5.4%)
USD 0.54
(-5.4%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -5.99 Million USD | 11.06% |
| 2023 | -6.73 Million USD | -75.64% |
| 2022 | -3.93 Million USD | 35.65% |
| 2021 | -7.05 Million USD | -214.52% |
| 2020 | -2.27 Million USD | 12.37% |
| 2019 | -2.2 Million USD | -76.84% |
| 2018 | -1.24 Million USD | -81.03% |
| 2017 | -689.34 Thousand USD | -22.3% |
| 2016 | -563.56 Thousand USD | -43.3% |
| 2015 | -393.15 Thousand USD | -79.32% |
| 2014 | -219.24 Thousand USD | -129.57% |
| 2013 | 741.47 Thousand USD | 8.22% |
| 2012 | 795.15 Thousand USD | 118.83% |
| 2011 | 313.08 Thousand USD | 232.78% |
| 2010 | -218.12 Thousand USD | -164.4% |
| 2009 | 383.35 Thousand USD | 163.77% |
| 2008 | 1.72 Million USD | -206.84% |
| 2007 | 537.48 Thousand USD | 2706.88% |
| 2006 | 24.95 Thousand USD | 81.49% |
| 2005 | -75.44 Thousand USD | 55.61% |
| 2004 | -171.97 Thousand USD | -54.13% |
| 2003 | -93.33 Thousand USD | 32.24% |
| 2002 | -273 Thousand USD | 53.99% |
| 2001 | -408.85 Thousand USD | 87.22% |
| 2000 | -3.96 Million USD | -1262.03% |
| 1999 | - USD | -250.0% |
| 1998 | 400 Thousand USD | -71.43% |
| 1997 | 800 Thousand USD | -30.0% |
| 1996 | 1 Million USD | 25.0% |
| 1995 | 800 Thousand USD | 33.33% |
| 1994 | 600 Thousand USD | 500.0% |
| 1993 | 200 Thousand USD | 114.29% |
| 1992 | -600 Thousand USD | 36.36% |
| 1991 | -1.1 Million USD | -237.5% |
| 1990 | 800 Thousand USD | 200.0% |
| 1989 | -800 Thousand USD | 46.67% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.51 Million USD | -33.07% |
| 2024 Q1 | -1.14 Million USD | 32.79% |
| 2024 Q4 | -1.43 Million USD | 30.9% |
| 2024 Q3 | -1.9 Million USD | -25.64% |
| 2024 FY | - USD | 12.79% |
| 2023 FY | - USD | -75.64% |
| 2023 Q3 | -1.56 Million USD | 3.44% |
| 2023 Q1 | -1.97 Million USD | -38.34% |
| 2023 Q2 | -1.62 Million USD | 17.87% |
| 2023 Q4 | -1.75 Million USD | -11.96% |
| 2022 Q4 | -1.42 Million USD | -13836.74% |
| 2022 Q1 | -1.44 Million USD | -4.09% |
| 2022 Q2 | -1.03 Million USD | 28.42% |
| 2022 Q3 | -10.23 Thousand USD | 99.01% |
| 2022 FY | - USD | 35.65% |
| 2021 FY | - USD | -214.52% |
| 2021 Q1 | -1.56 Million USD | -303.38% |
| 2021 Q3 | -1.75 Million USD | -26.84% |
| 2021 Q2 | -1.38 Million USD | 11.77% |
| 2021 Q4 | -1.38 Million USD | 20.94% |
| 2020 Q1 | -367.76 Thousand USD | 49.37% |
| 2020 Q3 | -776.01 Thousand USD | -93.96% |
| 2020 Q2 | -400.08 Thousand USD | -8.79% |
| 2020 FY | - USD | 12.37% |
| 2020 Q4 | -388.35 Thousand USD | 49.96% |
| 2019 Q1 | -407.73 Thousand USD | 30.78% |
| 2019 Q2 | -432.19 Thousand USD | -6.0% |
| 2019 Q3 | -668.14 Thousand USD | -54.6% |
| 2019 Q4 | -726.3 Thousand USD | -8.7% |
| 2019 FY | - USD | -76.84% |
| 2018 Q2 | -223.32 Thousand USD | -26.03% |
| 2018 Q1 | -177.19 Thousand USD | 38.94% |
| 2018 Q3 | -276.76 Thousand USD | -23.93% |
| 2018 FY | - USD | -81.03% |
| 2018 Q4 | -589.08 Thousand USD | -112.85% |
| 2017 Q4 | -290.18 Thousand USD | -15.41% |
| 2017 Q1 | -12.65 Thousand USD | 93.97% |
| 2017 FY | - USD | -22.3% |
| 2017 Q2 | -144.69 Thousand USD | -1043.44% |
| 2017 Q3 | -251.44 Thousand USD | -73.78% |
| 2016 Q2 | -138.22 Thousand USD | -929.63% |
| 2016 Q4 | -209.97 Thousand USD | -4.06% |
| 2016 Q1 | -13.42 Thousand USD | -355.37% |
| 2016 FY | - USD | -43.3% |
| 2016 Q3 | -201.77 Thousand USD | -45.97% |
| 2015 FY | - USD | -79.32% |
| 2015 Q3 | -67.31 Thousand USD | 61.59% |
| 2015 Q4 | 5257.00 USD | 107.81% |
| 2015 Q1 | -155.83 Thousand USD | -2310.98% |
| 2015 Q2 | -175.27 Thousand USD | -12.48% |
| 2014 Q1 | -123.53 Thousand USD | -272.93% |
| 2014 FY | - USD | -129.57% |
| 2014 Q3 | 87.37 Thousand USD | 144.52% |
| 2014 Q2 | -196.24 Thousand USD | -58.86% |
| 2014 Q4 | 7048.00 USD | -91.93% |
| 2013 FY | - USD | 8.22% |
| 2013 Q4 | 71.43 Thousand USD | 833.12% |
| 2013 Q3 | -9744.00 USD | -103.2% |
| 2013 Q2 | 304.15 Thousand USD | -16.97% |
| 2013 Q1 | 366.31 Thousand USD | 233.49% |
| 2012 Q2 | 237.64 Thousand USD | 48.58% |
| 2012 Q3 | 177.62 Thousand USD | -25.26% |
| 2012 Q4 | 109.84 Thousand USD | -38.16% |
| 2012 Q1 | 159.94 Thousand USD | -50.06% |
| 2012 FY | - USD | 118.83% |
| 2011 FY | - USD | 232.78% |
| 2011 Q3 | 113.94 Thousand USD | 135.65% |
| 2011 Q1 | 20.82 Thousand USD | 114.47% |
| 2011 Q2 | -319.58 Thousand USD | -1635.01% |
| 2011 Q4 | 320.3 Thousand USD | 181.11% |
| 2010 Q4 | -143.86 Thousand USD | -196.54% |
| 2010 Q2 | -273.94 Thousand USD | -915.5% |
| 2010 FY | - USD | -164.4% |
| 2010 Q1 | 33.59 Thousand USD | 37.42% |
| 2010 Q3 | 149.01 Thousand USD | 154.4% |
| 2009 Q3 | 240.07 Thousand USD | 359.2% |
| 2009 Q4 | 24.44 Thousand USD | -89.82% |
| 2009 Q1 | 156.28 Thousand USD | 158.95% |
| 2009 Q2 | -92.62 Thousand USD | -159.27% |
| 2009 FY | - USD | 163.77% |
| 2008 Q4 | -265.11 Thousand USD | -297.68% |
| 2008 FY | - USD | -206.84% |
| 2008 Q2 | 13.86 Thousand USD | -93.96% |
| 2008 Q1 | 229.64 Thousand USD | -18.14% |
| 2008 Q3 | 134.11 Thousand USD | 867.56% |
| 2007 Q3 | 70.64 Thousand USD | -45.08% |
| 2007 Q1 | 57.7 Thousand USD | -28.45% |
| 2007 FY | - USD | 2706.88% |
| 2007 Q4 | 280.51 Thousand USD | 297.09% |
| 2007 Q2 | 128.62 Thousand USD | 122.89% |
| 2006 Q3 | 46.82 Thousand USD | 189.86% |
| 2006 Q2 | -52.1 Thousand USD | 45.72% |
| 2006 Q1 | -95.98 Thousand USD | -122.8% |
| 2006 FY | - USD | 81.49% |
| 2006 Q4 | 80.64 Thousand USD | 72.24% |
| 2005 Q3 | 88.07 Thousand USD | 192.03% |
| 2005 FY | - USD | 55.61% |
| 2005 Q2 | -95.7 Thousand USD | -57.9% |
| 2005 Q1 | -60.6 Thousand USD | -219.29% |
| 2005 Q4 | -43.07 Thousand USD | -148.91% |
| 2004 Q3 | 114.22 Thousand USD | 191.23% |
| 2004 Q1 | -290.84 Thousand USD | -471.97% |
| 2004 FY | - USD | -54.13% |
| 2004 Q4 | 50.8 Thousand USD | -55.52% |
| 2004 Q2 | -125.2 Thousand USD | 56.95% |
| 2003 Q1 | -114.67 Thousand USD | -453.99% |
| 2003 FY | - USD | 32.24% |
| 2003 Q4 | 96.6 Thousand USD | 139.76% |
| 2003 Q3 | 31.79 Thousand USD | 128.96% |
| 2003 Q2 | -108.67 Thousand USD | 30.76% |
| 2002 Q3 | 94.05 Thousand USD | 764.82% |
| 2002 Q2 | -4013.00 USD | 97.57% |
| 2002 Q1 | -310.66 Thousand USD | -124.29% |
| 2002 FY | - USD | 53.99% |
| 2002 Q4 | 8033.00 USD | -16.05% |
| 2001 FY | - USD | 87.22% |
| 2001 Q1 | -145.64 Thousand USD | 6.34% |
| 2001 Q2 | 44.64 Thousand USD | 38.97% |
| 2001 Q3 | -480.2 Thousand USD | 17.92% |
| 2001 Q4 | 1.37 Million USD | 389.98% |
| 2000 Q4 | -1.16 Million USD | -7.42% |
| 2000 Q2 | -800 Thousand USD | -700.0% |
| 2000 Q1 | -600 Thousand USD | -200.0% |
| 2000 Q3 | -924.76 Thousand USD | -19.11% |
| 2000 FY | - USD | -1262.03% |
| 1999 FY | - USD | -250.0% |
| 1999 Q1 | - USD | 100.0% |
| 1999 Q2 | -100 Thousand USD | 0.0% |
| 1999 Q3 | -100 Thousand USD | 0.0% |
| 1999 Q4 | 200 Thousand USD | 200.0% |
| 1998 Q1 | 200 Thousand USD | 0.0% |
| 1998 Q2 | 200 Thousand USD | 0.0% |
| 1998 Q4 | -100 Thousand USD | -200.0% |
| 1998 Q3 | 100 Thousand USD | -50.0% |
| 1998 FY | - USD | -71.43% |
| 1997 Q4 | 200 Thousand USD | 0.0% |
| 1997 FY | - USD | -30.0% |
| 1997 Q1 | 300 Thousand USD | -20.0% |
| 1997 Q2 | 200 Thousand USD | -50.0% |
| 1997 Q3 | 200 Thousand USD | 0.0% |
| 1996 FY | - USD | 25.0% |
| 1996 Q4 | 500 Thousand USD | 400.0% |
| 1996 Q1 | 200 Thousand USD | -33.33% |
| 1996 Q3 | 100 Thousand USD | -50.0% |
| 1996 Q2 | 200 Thousand USD | 0.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 FY | - USD | 33.33% |
| 1995 Q4 | 300 Thousand USD | 50.0% |
| 1995 Q3 | 200 Thousand USD | 100.0% |
| 1995 Q1 | 100 Thousand USD | -66.67% |
| 1994 Q4 | 300 Thousand USD | 200.0% |
| 1994 Q2 | 100 Thousand USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q1 | 100 Thousand USD | 200.0% |
| 1994 FY | - USD | 500.0% |
| 1993 Q1 | 200 Thousand USD | 133.33% |
| 1993 FY | - USD | 114.29% |
| 1993 Q4 | -100 Thousand USD | -200.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | 100 Thousand USD | -50.0% |
| 1992 Q3 | -300 Thousand USD | -400.0% |
| 1992 Q4 | -600 Thousand USD | -100.0% |
| 1992 Q1 | 200 Thousand USD | 150.0% |
| 1992 Q2 | -100 Thousand USD | -50.0% |
| 1992 FY | - USD | 36.36% |
| 1991 FY | - USD | -237.5% |
| 1991 Q1 | 100 Thousand USD | -83.33% |
| 1991 Q2 | -400 Thousand USD | -500.0% |
| 1991 Q3 | -300 Thousand USD | 25.0% |
| 1991 Q4 | -400 Thousand USD | -33.33% |
| 1990 Q1 | -100 Thousand USD | 0.0% |
| 1990 Q3 | 100 Thousand USD | -66.67% |
| 1990 Q2 | 300 Thousand USD | 400.0% |
| 1990 Q4 | 700 Thousand USD | 500.0% |
| 1990 FY | - USD | 188.89% |
| 1989 Q3 | -300 Thousand USD | -200.0% |
| 1989 Q4 | -100 Thousand USD | 66.67% |
| 1989 FY | - USD | 64.0% |
| 1989 Q1 | 300 Thousand USD | 110.0% |
| 1989 Q2 | 300 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 55.565% |
| Cerus Corporation | -26.53 Million USD | 77.416% |
| OrthoPediatrics Corp. | -8.38 Million USD | 28.493% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 42.894% |
| Talis Biomedical Corporation | -66.04 Million USD | 90.926% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 64.06% |
| Inogen, Inc. | -45.67 Million USD | 86.88% |
| Spectral AI, Inc. | -12.26 Million USD | 51.125% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 87.434% |
| CVRx, Inc. | -38.73 Million USD | 84.527% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -69.87% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 50.5% |
| Orthofix Medical Inc. | -86.98 Million USD | 93.11% |
| Venus Concept Inc. | -26.11 Million USD | 77.05% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 87.959% |
| Bioventus Inc. | -23.07 Million USD | 74.023% |
| BrainsWay Ltd. | -2.31 Million USD | -159.325% |
| Envoy Medical, Inc. | -18.23 Million USD | 67.14% |
| electroCore, Inc. | -17.76 Million USD | 66.256% |
| IceCure Medical Ltd | -15.25 Million USD | 60.709% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 87.954% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 64.445% |
| MaxCyte, Inc. | -44.12 Million USD | 86.419% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 49.022% |
| Nexalin Technology, Inc. | -5.69 Million USD | -5.287% |
| PAVmed Inc | -75.74 Million USD | 92.088% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 88.852% |
| RxSight, Inc. | -41.03 Million USD | 85.396% |
| Sight Sciences, Inc. | -49.41 Million USD | 87.872% |
| SI-BONE, Inc. | -34.44 Million USD | 82.602% |
| TELA Bio, Inc. | -40.63 Million USD | 85.251% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 89.72% |
| Treace Medical Concepts, Inc. | -39 Million USD | 84.636% |
| LivaNova PLC | 39.01 Million USD | 115.36% |
| 908 Devices Inc. | -34.02 Million USD | 82.386% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 94.581% |
| Nemaura Medical Inc. | -7.28 Million USD | 17.758% |
| NeuroPace, Inc. | -22.83 Million USD | 73.754% |
| LENSAR, Inc. | -8.71 Million USD | 31.226% |
| Apyx Medical Corporation | -18.11 Million USD | 66.911% |
| Cutera, Inc. | -136.56 Million USD | 95.611% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -77.308% |
| BioSig Technologies, Inc. | -28.15 Million USD | 78.711% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 338.196% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 71.447% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 101.562% |
| Axonics, Inc. | 7.77 Million USD | 177.08% |
| Outset Medical, Inc. | -153.78 Million USD | 96.103% |
| IRIDEX Corporation | -7.44 Million USD | 19.535% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 93.891% |
| IRadimed Corporation | 20.8 Million USD | 128.812% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 25.664% |
| INVO Bioscience, Inc. | -6.88 Million USD | 12.893% |
| Telesis Bio, Inc. | -40.49 Million USD | 85.2% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 116.34% |
| Varex Imaging Corporation | 67.2 Million USD | 108.918% |
| Quipt Home Medical Corp. | 44.07 Million USD | 113.599% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 44.867% |
| Pulmonx Corporation | -55.09 Million USD | 89.122% |
| Dynatronics Corporation | -976 Thousand USD | -514.032% |
| Modular Medical, Inc. | -17.1 Million USD | 64.959% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 58.626% |
| Semler Scientific, Inc. | 23.58 Million USD | 125.406% |
| InMode Ltd. | 196.28 Million USD | 103.053% |
| Bruker Corporation | 599 Million USD | 101.001% |
| Cytosorbents Corporation | -28.81 Million USD | 79.199% |
| DexCom, Inc. | 916.7 Million USD | 100.654% |
| Align Technology, Inc. | 799.03 Million USD | 100.75% |
| Viveve Medical, Inc. | -20.61 Million USD | 70.932% |
| ZimVie Inc. | 91.07 Million USD | 106.58% |
| Movano Inc. | -29.12 Million USD | 79.423% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -35.957% |
| Nexalin Technology, Inc. | -5.69 Million USD | -5.287% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -69.87% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 96.921% |
| Profound Medical Corp. | -27.12 Million USD | 77.905% |
| Insulet Corporation | 323.6 Million USD | 101.852% |
| enVVeno Medical Corporation | -25.01 Million USD | 76.045% |
| Surmodics, Inc. | 1.18 Million USD | 604.461% |
| iCAD, Inc. | -6.56 Million USD | 8.713% |
| Nuwellis, Inc. | -16.35 Million USD | 63.359% |
| Biotricity, Inc. | -8.82 Million USD | 32.116% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 93.813% |
| Aethlon Medical, Inc. | -11.84 Million USD | 49.422% |
| InspireMD, Inc. | -20.91 Million USD | 71.34% |
| PAVmed Inc. | -75.74 Million USD | 92.088% |
| BIOLASE, Inc. | -15.13 Million USD | 60.414% |
| Beyond Air, Inc. | -59.03 Million USD | 89.848% |
| FONAR Corporation | 28.25 Million USD | 121.213% |
| AxoGen, Inc. | -13.32 Million USD | 55.035% |
| Vivani Medical, Inc. | -26.6 Million USD | 77.477% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 124.42% |
| Inari Medical, Inc. | 7.11 Million USD | 184.254% |
| UFP Technologies, Inc. | 72.74 Million USD | 108.239% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -77.005% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 2.648% |
| Tenon Medical, Inc. | -15.52 Million USD | 61.405% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 60.743% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 85.551% |
| AdaptHealth Corp. | -171.09 Million USD | 96.497% |
| Sintx Technologies, Inc. | -6.6 Million USD | 9.197% |
| NanoVibronix, Inc. | -3.43 Million USD | -74.469% |
| Quanterix Corporation | -38.08 Million USD | 84.265% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 44.867% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 20076.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 97.839% |
| TransMedics Group, Inc. | -7.6 Million USD | 21.176% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 72.465% |
| NeuroMetrix, Inc. | -7.09 Million USD | 15.542% |
| Hyperfine, Inc. | -47.06 Million USD | 87.265% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 89.722% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1349.656% |
| AVITA Medical, Inc. | -39.56 Million USD | 84.854% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 34.666% |
| Silk Road Medical, Inc | -45.08 Million USD | 86.706% |